PERMANENT AWARD EVIDENCE
NHS England · published 8 Aug 2025. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.
28634f74-ef5a-4f72-a69e-bea1cff17430-858255ocds-b5fd17-e81f15b0-0645-4262-9961-872ebf60ed9eGB-CFS-323043A tender estimate and an award value answer different questions. Neither is treated as cash paid.
NHS National Pharmaceuticals Generic Products - Wave 15b Offer reference number: CM/PHG/23/5698 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. FIND A TENDER (FTS) Reference number: 2025/S 000-005420 Potential periods of call-offs under the framework agreement: CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months) NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months) LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months) CM/PHG/23/5698/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months) CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months) DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months) DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)
The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.
A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.
No legal entity is inferred from this supplier name.
Published 8 Aug 2025 · held through the daily award projection · Open Government Licence v3.0.